These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1409810)

  • 61. Lack of altered startle responding in rats following termination of self-administered or noncontingently infused cocaine.
    Mansbach RS; Markou A; Patrick GA
    Pharmacol Biochem Behav; 1994 Jun; 48(2):453-8. PubMed ID: 8090814
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of SCH 23390 on the apomorphine subsensitivity in the substantia nigra and ventral tegmental area 1 day following withdrawal from continuous or intermittent cocaine pretreatment.
    Lee TH; Gao WY; Ellinwood EH
    Brain Res; 1997 Jan; 744(2):293-301. PubMed ID: 9027389
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
    Heidbreder CA; Thompson AC; Shippenberg TS
    J Pharmacol Exp Ther; 1996 Aug; 278(2):490-502. PubMed ID: 8768696
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Behavioral responses during the initial exposures to a low dose of cocaine in late preweanling and adult rats.
    Smith KS; Morrell JI
    Neurotoxicol Teratol; 2008; 30(3):202-12. PubMed ID: 18276106
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sex differences in cocaine-induced behavioral sensitization.
    Chin J; Sternin O; Wu HB; Fletcher H; Perrotti LI; Jenab S; Quiñones-Jenab V
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1089-95. PubMed ID: 11785661
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Repeated intravenous cocaine administration to rats produces behavioral sensitization without changing brain cocaine levels.
    Orona RA; Mayfield RD; Cline EJ; Zahniser NR
    Neurosci Lett; 1994 Feb; 167(1-2):121-4. PubMed ID: 8177509
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of cocaine sensitization: regulation by the medial prefrontal cortex.
    Prasad BM; Hochstatter T; Sorg BA
    Neuroscience; 1999; 88(3):765-74. PubMed ID: 10363816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cross-sensitization of the reinforcing effects of cocaine and amphetamine in rats.
    Liu Y; Morgan D; Roberts DC
    Psychopharmacology (Berl); 2007 Dec; 195(3):369-75. PubMed ID: 17710385
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The neurochemical basis for the behavioral effects of triadimefon.
    Hill D; Ikaiddi M; Mazzio E; Soliman KF
    Ann N Y Acad Sci; 2000 Sep; 914():336-53. PubMed ID: 11085334
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose "binge" cocaine administration paradigm.
    Bailey A; Gianotti R; Ho A; Kreek MJ
    Synapse; 2007 Oct; 61(10):820-6. PubMed ID: 17621646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine.
    Dunn JM; Inderwies BR; Licata SC; Pierce RC
    Psychopharmacology (Berl); 2005 Apr; 179(1):172-80. PubMed ID: 15580483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats.
    Dow-Edwards D; Fico TA; Osman M; Gamagaris Z; Hutchings DE
    Pharmacol Biochem Behav; 1989 May; 33(1):167-73. PubMed ID: 2780773
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Behavioral neurobiological effects of chronic cocaine administration: contrasts between administration paradigms as well as times after withdrawal.
    Ellinwood EH; King G; Lee TH; Joyner CM; Zhang H
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():646A-647A. PubMed ID: 1498987
    [No Abstract]   [Full Text] [Related]  

  • 74. The actions of nicotine and cocaine in a mouse model of anxiety.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES
    Pharmacol Biochem Behav; 1989 May; 33(1):197-203. PubMed ID: 2780777
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Physiological and subjective effects of acute cocaine withdrawal (crash) in rats.
    Gauvin DV; Briscoe RJ; Baird TJ; Vallett M; Carl KL; Holloway FA
    Pharmacol Biochem Behav; 1997 Aug; 57(4):923-34. PubMed ID: 9259025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A rodent model of cocaine abstinence syndrome.
    Malin DH; Moon WD; Moy ET; Jennings RE; Moy DM; Warner RL; Wilson OB
    Pharmacol Biochem Behav; 2000 Jun; 66(2):323-8. PubMed ID: 10880685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Technique for the continuous infusion of high doses of cocaine by osmotic minipump.
    Joyner C; King G; Lee TH; Ellinwood EH
    Pharmacol Biochem Behav; 1993 Apr; 44(4):971-3. PubMed ID: 8469707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A silicone pellet for continuous cocaine: comparison with continuous amphetamine.
    Lipton J; Zeigler S; Wilkins J; Ellison G
    Pharmacol Biochem Behav; 1991 Apr; 38(4):927-30. PubMed ID: 1871207
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Augmentation of the behavioral and electrophysiologic response to cocaine by chronic administration in the rat.
    Stripling JS; Ellinwood EH
    Exp Neurol; 1977 Mar; 54(3):546-64. PubMed ID: 844525
    [No Abstract]   [Full Text] [Related]  

  • 80. Technical report: the subcutaneous administration of cocaine in the rat.
    Durazzo TC; Gauvin DV; Goulden KL; Briscoe RJ; Holloway FA
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1007-10. PubMed ID: 7886068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.